TTM
$18.96B
YoY change
+10.6%
5Y CAGR
+18.8%
Peak year (2025)
$15.97B
Cumulative net income
$127.88B
Net Income history chart for Novo Nordisk (NVO) from 1985 to 2025
Latest: $15.97B
Net Income growth chart for Novo Nordisk (NVO) from 1985 to 2025
Latest: +10.6%
Net Income history table for Novo Nordisk (NVO) from 1985 to 2025
| 2025 | $15.97B | +10.6% | +$1.53B | ||
| 2024 | $14.44B | +19.6% | +$2.36B | ||
| 2023 | $12.08B | +58.3% | +$4.45B | ||
| 2022 | $7.63B | +3.9% | +$287.47M | ||
| 2021 | $7.34B | +8.7% | +$587.67M | ||
| 2020 | $6.75B | +17.0% | +$981.36M | ||
| 2019 | $5.77B | -2.2% | −$132.78M | ||
| 2018 | $5.91B | -2.1% | −$128.15M | ||
| 2017 | $6.03B | +9.8% | +$538.26M | ||
| 2016 | $5.50B | +7.4% | +$378.04M | ||
| 2015 | $5.12B | +15.2% | +$673.92M | ||
| 2014 | $4.44B | -3.3% | −$153.57M | ||
| 2013 | $4.60B | +23.3% | +$868.67M | ||
| 2012 | $3.73B | +20.4% | +$632.09M | ||
| 2011 | $3.10B | +18.0% | +$472.65M | ||
| 2010 | $2.62B | +22.8% | +$487.14M | ||
| 2009 | $2.14B | +24.7% | +$423.85M | ||
| 2008 | $1.71B | +3.3% | +$54.48M | ||
| 2007 | $1.66B | +48.5% | +$541.59M | ||
| 2006 | $1.12B | +19.6% | +$182.79M | ||
| 2005 | $933.75M | +5.9% | +$51.64M | ||
| 2004 | $882.11M | +9.4% | +$76.00M | ||
| 2003 | $806.11M | — | — | ||
| 2002 | — | — | — | ||
| 2001 | — | — | — | ||
| 2000 | — | — | — | ||
| 1999 | — | — | — | ||
| 1998 | — | — | — | ||
| 1997 | — | — | — | ||
| 1996 | — | — | — | ||
| 1995 | — | — | — | ||
| 1994 | — | — | — | ||
| 1993 | — | — | — | ||
| 1992 | — | — | — | ||
| 1991 | — | — | — | ||
| 1990 | — | — | — | ||
| 1989 | — | — | — | ||
| 1988 | — | — | — | ||
| 1987 | — | — | — | ||
| 1986 | — | — | — | ||
| 1985 | — | — | — |
- 2025$15.97B+10.6%
- 2024$14.44B+19.6%
- 2023$12.08B+58.3%
- 2022$7.63B+3.9%
- 2021$7.34B+8.7%
- 2020$6.75B+17.0%
- 2019$5.77B-2.2%
- 2018$5.91B-2.1%
- 2017$6.03B+9.8%
- 2016$5.50B+7.4%
- 2015$5.12B+15.2%
- 2014$4.44B-3.3%
- 2013$4.60B+23.3%
- 2012$3.73B+20.4%
- 2011$3.10B+18.0%
- 2010$2.62B+22.8%
- 2009$2.14B+24.7%
- 2008$1.71B+3.3%
- 2007$1.66B+48.5%
- 2006$1.12B+19.6%
- 2005$933.75M+5.9%
- 2004$882.11M+9.4%
- 2003$806.11M—
- 2002——
- 2001——
- 2000——
- 1999——
- 1998——
- 1997——
- 1996——
- 1995——
- 1994——
- 1993——
- 1992——
- 1991——
- 1990——
- 1989——
- 1988——
- 1987——
- 1986——
- 1985——
Net Income values are taken from Novo Nordisk's reported income statements (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts converted to USD using IAS 21 average exchange rates (P&L / cash flow) or closing rates (balance sheet). Originally filed in DKK.
About Net Income at Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's current net income (TTM) is $18.96B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Novo Nordisk (NVO) reported net income of 102.43B DKK – edged up 1.4% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Novo Nordisk net income compounded at +19.4% per year, sustaining 38 straight years of year-over-year growth.
2025 marks the peak net income at 102.43B DKK, with the historical low of 480.40M DKK recorded in 1987.
Novo Nordisk Net Income by Year
Novo Nordisk Net Income 2025: $15.97B
Novo Nordisk posted net income of 102.43B DKK ($15.97B) in 2025, edged up 1.4% from 2024. This figure represents the highest annual value in the available history.
Novo Nordisk Net Income 2024: $14.44B
In 2024, Novo Nordisk reported net income of 100.99B DKK ($14.44B), grew 20.7% from 2023.
Novo Nordisk Net Income 2023: $12.08B
Novo Nordisk net income in 2023 was 83.68B DKK ($12.08B), surged 50.7% from 2022.
Novo Nordisk Net Income 2022: $7.63B
2022's net income for Novo Nordisk came in at 55.52B DKK ($7.63B), grew 16.3% from 2021.
Novo Nordisk Net Income 2021: $7.34B
Novo Nordisk net income in 2021 was 47.76B DKK ($7.34B).
See more financial history for Novo Nordisk (NVO).
Sector peers by Net Income
Healthcare peers of Novo Nordisk (NVO), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $6.74B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation